Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
114 studies found for:    "Ocular motility disorders"
Show Display Options
RSS Create an RSS feed from your search for:
"Ocular motility disorders"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Evaluation and Treatment of Pediatric Eye Diseases
Condition: Ocular Motility Disorder
Intervention: Procedure: current standard of care treatments
2 Enrolling by invitation Frontoparietal Priority Maps as Biomarkers for MTBI
Conditions: TBI (Traumatic Brain Injury);   Ocular Motility Disorders
Intervention:
3 Recruiting MRI Study of Brain Activity in Healthy Adults and Individuals With Parkinsonism and Rapid Eye Movement Disorder.
Conditions: Movement Disorders (Incl Parkinsonism);   Tremor Familial Essential, 1;   REM Sleep Behavior Disorder
Intervention:
4 Completed Screening for Studies on Nystagmus and Strabismus
Conditions: Nystagmus;   Strabismus
Intervention:
5 Recruiting Office-based Vision Therapy for Improving Reading and Attention in Children With Convergence Insufficiency
Condition: Convergence Insufficiency
Intervention: Procedure: Office-based vergence/accommodative therapy
6 Recruiting Convergence Insufficiency Treatment Study (CITS)
Condition: Convergence Insufficiency
Interventions: Other: Active home-based computer vergence/accommodative therapy;   Procedure: Near target push-ups;   Other: Placebo home-based computer vergence/accommodative therapy;   Procedure: Placebo yoked prism flippers
7 Completed Surgery and Convergence Insufficiency Intermittent Exotropia
Condition: Complications
Interventions: Procedure: Post exercise Surgery;   Procedure: Orthoptics;   Procedure: Postop orthoptics;   Procedure: Post exercises surgery
8 Completed Study of Eyes and Attention Deficit (SEAD)
Conditions: ADHD;   Convergence Insufficiency;   Accommodative Insufficiency
Intervention:
9 Unknown  Convergence Insufficiency Treatment Trial (CITT)
Conditions: Convergence Insufficiency;   Binocular Vision Disorder
Interventions: Behavioral: Home-based Pencil Push-Up Therapy;   Behavioral: Home-based Pencil Push-ups with Computer Vision Therapy/Orthoptics;   Behavioral: Office-based Vision Therapy/Orthoptics;   Behavioral: Placebo Office-based Vision Therapy/Orthoptics
10 Unknown  Use of Rituximab in Opsoclonus-Myoclonus in Children With Neuroblastoma
Conditions: Neuroblastoma;   Opsoclonus-Myoclonus
Intervention: Drug: anti-CD20 (Rituximab)
11 Completed Effectiveness of Rituximab in Pediatric OMS Patients.
Conditions: Opsoclonus-myoclonus Syndrome;   Opsoclonus;   Myoclonus;   Ataxia
Intervention: Drug: rituximab
12 Completed A Randomized Trial of Base-in Prism Reading Glasses Convergence Insufficiency in Children
Condition: Convergence Insufficiency
Interventions: Procedure: Base-in prism glasses for reading;   Procedure: Placebo reading glasses
13 Completed Randomized Trial of Treatments for Convergence Insufficiency
Condition: Convergence Insufficiency
Interventions: Procedure: Pencil Push-ups;   Procedure: Office-based Vision Therapy;   Procedure: Placebo Office-based Vision Therapy
14 Completed Eye Teaming Evaluation Study
Condition: Convergence Insufficiency
Intervention: Device: NPC targets
15 Unknown  Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes
Conditions: Parkinson's Disease;   Parkinsonian Syndrome;   Multiple System Atrophy;   Supranuclear Palsy, Progressive;   Essential Tremor;   Vascular Parkinsonism;   Drug Induced Parkinsonism
Intervention:
16 Completed Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Interventions: Drug: tideglusib;   Drug: placebo
17 Recruiting Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders, PD,Essential Tremor, (ET),Cortical Basal Degeneration, (CBD),Multiple Systems Atrophy (MSA), Magnetoencephalography
Conditions: Essential Tremor;   Multiple System Atrophy;   Corticobasal Degeneration;   Supranuclear Palsy, Progressive
Intervention:
18 Recruiting 4 Repeat Tauopathy Neuroimaging Initiative
Conditions: Progressive Supranuclear Palsy;   Corticobasal Degeneration
Intervention: Other: Observational Study
19 Completed Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy
Interventions: Drug: Davunetide;   Drug: Placebo
20 Available Expanded Access Study of Amifampridine Phosphate in LEMS, Congenital Myasthenic Syndrome, or Downbeat Nystagmus Patients
Conditions: Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome;   Downbeat Nystagmus
Intervention: Drug: Amifampridine Phosphate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years